Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/176211
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fernández Dueñas, Víctor | - |
dc.contributor.author | Ferré, Sergi | - |
dc.contributor.author | Ciruela Alférez, Francisco | - |
dc.date.accessioned | 2021-04-13T09:03:22Z | - |
dc.date.available | 2021-04-13T09:03:22Z | - |
dc.date.issued | 2018-02-01 | - |
dc.identifier.issn | 1673-5374 | - |
dc.identifier.uri | http://hdl.handle.net/2445/176211 | - |
dc.description.abstract | The basal ganglia (BG) assemble a series of deep gray matter structures forming recurrent loops that include the cortex and thalamus, and that participate in the regulation of a plethora of brain functions, including elicitation and learn ing of reward-and aversive stimuli-associated behaviors, motor activity control and sensorimotor gating (Brom berg-Martin et al., 2010). The striatum is the main input BG structure, thus it receives cortical glutamatergic projections from widespread areas of cortex and projects into other BG nuclei, including globus pallidus pars externa and the BG outputsglobus pallidus pars interna and substantia nigra pars reticulata. On the other hand, the substantia nigra pars compacta-ventral tegmental area (SNpc-VTA) modulates cortical-BG-thalamic circuits by means of dopaminergic innervation of the striatum. Interestingly, the main popula tion of striatal neurons, the medium spiny neurons (MSNs), provide the origin of two different striatal efferent pathways, the direct and indirect pathways (Schiffmann et al., 2007). | - |
dc.format.extent | 3 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Wolters Kluwer - Medknow | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.4103/1673-5374.226388 | - |
dc.relation.ispartof | Neural Regeneration Research, 2018, vol. 13, num. 2, p. 241-243 | - |
dc.relation.uri | https://doi.org/10.4103/1673-5374.226388 | - |
dc.rights | cc-by-nc-sa (c) Neural Regeneration Research, 2018 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/es | - |
dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | - |
dc.subject.classification | Malaltia de Parkinson | - |
dc.subject.classification | Adenosina | - |
dc.subject.classification | Dopamina | - |
dc.subject.classification | Receptors cel·lulars | - |
dc.subject.other | Parkinson's disease | - |
dc.subject.other | Adenosine | - |
dc.subject.other | Dopamine | - |
dc.subject.other | Cell receptors | - |
dc.title | Adenosine A2A-dopamine D2 receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 679454 | - |
dc.date.updated | 2021-04-13T09:03:22Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 29557372 | - |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
679454.pdf | 513.36 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License